7.1
HIGH CVSS 4.0
CVE-2026-50034
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
Description

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

INFO

Published Date :

June 18, 2026, 11:47 p.m.

Last Modified :

June 18, 2026, 11:47 p.m.

Remotely Exploit :

No

Source :

icscert
Affected Products

The following products are affected by CVE-2026-50034 vulnerability. Even if cvefeed.io is aware of the exact versions of the products that are affected, the information is not represented in the table below.

No affected product recoded yet

CVSS Scores
The Common Vulnerability Scoring System is a standardized framework for assessing the severity of vulnerabilities in software and systems. We collect and displays CVSS scores from various sources for each CVE.
Score Version Severity Vector Exploitability Score Impact Score Source
CVSS 3.1 MEDIUM 7d14cffa-0d7d-4270-9dc0-52cabd5a23a6
CVSS 4.0 HIGH 7d14cffa-0d7d-4270-9dc0-52cabd5a23a6
Solution
Implement stronger encryption and authentication for BLE communication to protect sensitive data.
  • Enforce strong encryption for BLE traffic.
  • Enable authentication for BLE connections.
  • Consider using secure protocols for data transmission.
  • Regularly review BLE security settings.

We scan GitHub repositories to detect new proof-of-concept exploits. Following list is a collection of public exploits and proof-of-concepts, which have been published on GitHub (sorted by the most recently updated).

Results are limited to the first 15 repositories due to potential performance issues.

The following list is the news that have been mention CVE-2026-50034 vulnerability anywhere in the article.

EPSS is a daily estimate of the probability of exploitation activity being observed over the next 30 days. Following chart shows the EPSS score history of the vulnerability.